ARCHIVES

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

This article is from The Cancer Letter archive.

Vol. 07 No. 40 | October 2, 1981

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

March 11, 1994

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

House Subcommittee To Hold Hearings On Cancer Program

June 10, 1977

NCAB: An Extraordinary Opportunity For Budgetary Coordination.

February 25, 2000